DNA vaccination against VEGF receptor 2 reduces atherosclerosis in LDL receptor-deficient mice

被引:53
作者
Petrovan, Ramona J. [1 ]
Kaplan, Charles D. [1 ]
Reisfeld, Ralph A. [1 ]
Curtiss, Linda K. [1 ]
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
关键词
atherosclerosis; vaccination; plaque; endothelium; neovessels;
D O I
10.1161/ATVBAHA.106.139246
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - Similarities between neovascular ingrowth in atherosclerotic plaques and angiogenesis in tumors suggest that antiangiogenic factors that target tumor expansion may prove efficacious in the treatment of atherosclerosis. This study examined whether an oral DNA vaccine against the murine VEGF receptor 2 (Flk-1) with demonstrated antitumor effect through inhibition of pathological neovascularization can prevent or retard progression of atherosclerosis in hyperlipidemic low density lipoprotein receptor-deficient (LDLr-/-) mice. Methods and Results - Vaccination against Flk-1 resulted in T cell activation, suppression of neoangiogenesis, and a marked reduction in atherosclerosis which was independent of hypercholesterolemia in both male and female mice. Immunohistochemical characterization of aortic sinus lesions showed that the decreased lesion area was not associated with reduced plaque stability and had a lower density of microvessels. Conclusions - These findings demonstrate for the first time that a DNA vaccine targeting activated endothelial cells in atherosclerotic lesions provides direct atheroprotective effects.
引用
收藏
页码:1095 / 1100
页数:6
相关论文
共 29 条
[21]   A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth [J].
Niethammer, AG ;
Xiang, R ;
Becker, JC ;
Wodrich, H ;
Pertl, U ;
Karsten, G ;
Eliceiri, BP ;
Reisfeld, RA .
NATURE MEDICINE, 2002, 8 (12) :1369-1375
[22]   Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content [J].
OBrien, KD ;
McDonald, TO ;
Chait, A ;
Allen, MD ;
Alpers, CE .
CIRCULATION, 1996, 93 (04) :672-682
[23]   Immunotherapy with a posttranscriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma [J].
Pertl, U ;
Wodrich, H ;
Ruehlmann, JM ;
Gillies, SD ;
Lode, HN ;
Reisfeld, RA .
BLOOD, 2003, 101 (02) :649-654
[24]   Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2 [J].
Roeckl, W ;
Hecht, D ;
Sztajer, H ;
Waltenberger, J ;
Yayon, A ;
Weich, HA .
EXPERIMENTAL CELL RESEARCH, 1998, 241 (01) :161-170
[25]   Mechanisms of disease - Atherosclerosis - An inflammatory disease [J].
Ross, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (02) :115-126
[26]   Effect of γ-irradiation and bone marrow transplantation on atherosclerosis in LDL receptor-deficient mice [J].
Schiller, NK ;
Kubo, N ;
Boisvert, WA ;
Curtiss, LK .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (10) :1674-1680
[27]   Adenovirus-mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice [J].
Tseng, JF ;
Farnebo, FA ;
Kisker, O ;
Becker, CM ;
Kuo, CJ ;
Folkman, J ;
Mulligan, RC .
SURGERY, 2002, 132 (05) :857-865
[28]   Atherosclerotic plaque progression and vulnerability to rupture - Angiogenesis as a source of intraplaque hemorrhage [J].
Virmani, R ;
Kolodgie, FD ;
Burke, AP ;
Finn, AV ;
Gold, HK ;
Tulenko, TN ;
Wrenn, SP ;
Narula, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (10) :2054-2061
[29]   T cell-mediated suppression of angiogenesis results in tumor protective immunity [J].
Zhou, H ;
Luo, YP ;
Mizutani, M ;
Mizutani, N ;
Reisfeld, RA ;
Xiang, R .
BLOOD, 2005, 106 (06) :2026-2032